Principal Investigators

    J. Koistinaho, L.Roybon, G.Gouras, C.Rampon, D.Brites, MT.Heneka, F.Edenhofer, T.Malm



    Contact information of lead PI



    Title of project or programme

    MADGIC: Generation of Improved Cellular and Animal Models for Identification of Disease Phenotype and New Therapeutic Targets of Alzheimer’s Disease

    Source of funding information


    Total sum awarded (Euro)

    € 1,901,835

    Start date of award


    Total duration of award in years


    The project/programme is most relevant to:

    Alzheimer's disease & other dementias


    Research Abstract

    The mechanisms of Alzheimer’s disease (AD) have remained poorly understood while com- mon animal models have not helped in finding efficient therapies for the disease. This pro- ject aims to generate new human cellular models allowing for the purification of specific neural cell types involved in AD. We generate patient neural cells through reprogramming patients’ skin cells, grow them alone or in mixed 3-dimensional cultures, and use them to ad- dress disease relevant mechanisms both in a dish and in animals after transplantation. Such approaches will allow for the characterization of cellular dysfunction and death pro- cesses in neurons and their supporting glia cells and will help establish whether neuroinflam- mation by glial cells truly determines the disease progression. We will substantiate our ap- proaches through the implementation of relevant stressors known to contribute to AD path- ogenesis, considering the relationships between risk (such as aging, ischemic insults, inflam- mation, oxidative stress), protective factors and genetic determinants. The usefulness of our approach will be confirmed by monitoring disease progression using innovative imaging techniques. As our AD models are based on human cells, they are clinically relevant and are expected help lead to the development of early diagnosis and the design of drugs and the application of personalized treatments for people suffering from AD.

    Lay Summary

    Further information available at:

Types: Investments > €500k, JPND Projects
Member States: Finland, France, Germany, JPND, Portugal, Sweden
Diseases: Alzheimer's disease & other dementias
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF